This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Ajuga remota
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
East African highland herb used for malaria, fever, and immune support; one of the most tested East African plants for antimalarial activity.
East African highland herb used for malaria, fever, and immune support; one of the most tested East African plants for antimalarial activity. Key active compounds include ajugaremotine, 8-O-acetylharpagide, iridoid glycosides.
ajugaremotine, along with 8-O-acetylharpagide and iridoid glycosides, are the primary bioactive compounds in Ajuga Remota. These compounds modulates NF-κB and COX-2 inflammatory pathways, improves insulin sensitivity and glucose metabolism.
Antimalarial activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Hypoglycemic effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-inflammatory properties
Immunomodulation
Malaria treatment
Based on traditional use; clinical evidence limited
Fever reduction
Based on traditional use; clinical evidence limited
Immune support
Based on traditional use; clinical evidence limited
Diabetes management
Based on traditional use; clinical evidence limited
Found an error or have a correction for Ajuga Remota?
Report an Issue →